RESUMEN

CD11c+/CD11b+dendritic cells (DC) with high levels of major histocompatibility complex (MHC) class II and co-stimulatory molecules have been derived from spleen cells cultured with granulocyte-macrophage colony stimulating factor (GM-CSF) + flt-3L + interleukin (IL)-6 (flt-3L-DC). Investigating in vivo the function of DC in non-obese diabetic mice (NOD), we showed that a single injection of this in vitro-derived subset of DC prevents the development of diabetes into prediabetic female mice. In contrast, DC derived from bone marrow cells cultured with GM-CSF + IL-4 [bone marrow (BM)-DC] induced no protection. Moreover, protection against diabetes following injection of flt-3L-DC was associated with IL-4 and IL-10 production in the spleen and the pancreatic lymph nodes of recipient mice, indicating that this DC population is able to polarize the immune response towards a Th2 pathway. As we shown previously, NOD BM-DC exhibit an enhanced capacity to produce IL-12p70 in response to lipopolysaccharide (LPS) and anti-CD40 stimulation compared to BM-DC from control mice. In contrast, NOD flt-3L-DC, as their control mouse counterpart, produced no IL-12p70 to these stimuli. Our findings show that a subset of DC, characterized by a mature phenotype and the absence of IL-12p70 production can be derived from NOD mouse spleen favouring IL-4 and IL-10 regulatory responses and protection from diabetes development.

Asunto(s)

Células Dendríticas/inmunología , Diabetes Mellitus/prevención & control , Inmunoterapia Adoptiva/métodos , Interleucinas/biosíntesis , Proteínas de la Membrana/inmunología , Bazo/inmunología , Animales , Células Cultivadas , Diabetes Mellitus/inmunología , Femenino , Factor Estimulante de Colonias de Granulocitos y Macrófagos/farmacología , Interleucina-10/biosíntesis , Interleucina-10/inmunología , Interleucina-4/biosíntesis , Interleucina-4/inmunología , Interleucinas/inmunología , Ganglios Linfáticos/inmunología , Ratones , Ratones Endogámicos NOD

RESUMEN

Type 1 diabetes (T1D) in non-obese diabetic (NOD) mice may be favored by immune dysregulation leading to the hyporesponsiveness of regulatory T cells and activation of effector T-helper type 1 (Th1) cells. The immunoregulatory activity of natural killer T (NKT) cells is well documented, and both interleukin (IL)-4 and IL-10 secreted by NKT cells have important roles in mediating this activity. NKT cells are less frequent and display deficient IL-4 responses in both NOD mice and individuals at risk for T1D (ref. 8), and this deficiency may lead to T1D (refs. 1,6-9). Thus, given that NKT cells respond to the alpha-galactosylceramide (alpha-GalCer) glycolipid in a CD1d-restricted manner by secretion of Th2 cytokines, we reasoned that activation of NKT cells by alpha-GalCer might prevent the onset and/or recurrence of T1D. Here we show that alpha-GalCer treatment, even when initiated after the onset of insulitis, protects female NOD mice from T1D and prolongs the survival of pancreatic islets transplanted into newly diabetic NOD mice. In addition, when administered after the onset of insulitis, alpha-GalCer and IL-7 displayed synergistic effects, possibly via the ability of IL-7 to render NKT cells fully responsive to alpha-GalCer. Protection from T1D by alpha-GalCer was associated with the suppression of both T- and B-cell autoimmunity to islet beta cells and with a polarized Th2-like response in spleen and pancreas of these mice. These findings raise the possibility that alpha-GalCer treatment might be used therapeutically to prevent the onset and recurrence of human T1D.

Asunto(s)

Diabetes Mellitus Tipo 1/prevención & control , Galactosilceramidas/farmacología , Células Asesinas Naturales/inmunología , Animales , Anticuerpos Monoclonales/farmacología , Antígenos CD1/genética , Ciclofosfamida/toxicidad , Diabetes Mellitus Tipo 1/inducido químicamente , Diabetes Mellitus Tipo 1/inmunología , Interferón gamma/metabolismo , Interleucina-4/metabolismo , Interleucina-7/farmacología , Células Asesinas Naturales/efectos de los fármacos , Selectina L/metabolismo , Activación de Linfocitos , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos NOD , Ratones Mutantes , Receptores de Interleucina/efectos de los fármacos , Receptores de Interleucina/inmunología , Receptores de Interleucina-10 , Bazo/efectos de los fármacos , Bazo/metabolismo

RESUMEN

There is compelling evidence to show that insulin dependent diabetes ensues from selective apoptosis of pancreatic beta-cells mediated by autoreactive T-lymphocytes. The respective implication in this phenomenon of the various apoptotic pathways driven by Fas, perforin, or tumor necrosis factor is still ill- defined. Here we took advantage of the cyclophosphamide-induced model of accelerated diabetes in NOD mice to explore the physiopathological role of the Fas-Fas Ligand pathway. A single injection of cyclophosphamide (200 mg/kg) to 7-8 week-old prediabetic NOD mice triggered diabetes within 10-15 days in 85-100% of the animals. Cyclophosphamide also induced a significant decrease in spleen T cells, that was most evident by days 6-10 after treatment, and selectively affected the CD3(+)CD62L(+)compartment that includes immunoregulatory T cells. To block the in vivo Fas-Fas ligand (Fas L) interaction we administered a biologically active recombinant fusion protein coupling mouse Fas to the Fc portion of human IgG1 (FAS-Fc). Mice treated with FAS-Fc (10 doses iv of 15 microg) starting on the day of cyclophosphamide injection up to day 22, were fully protected from disease. Unexpectedly this protective effect was not due to blockade of Fas-FasL-mediated beta-cell apoptosis but rather to the inhibition of the cyclophosphamide effect on T cells. Indeed FAS-Fc treatment prevented the drug-induced T cell depletion in general and that of immunoregulatory T cells in particular. Additionally, FAS-Fc administration limited to the phase of beta-cell destruction did not afford any protection.

Asunto(s)

Diabetes Mellitus Tipo 1/inmunología , Glicoproteínas de Membrana/inmunología , Linfocitos T/inmunología , Receptor fas/inmunología , Animales , Linfocitos B/citología , Linfocitos B/inmunología , Ciclofosfamida/efectos adversos , Diabetes Mellitus Tipo 1/inducido químicamente , Proteína Ligando Fas , Humanos , Inmunosupresores/efectos adversos , Islotes Pancreáticos/citología , Islotes Pancreáticos/inmunología , Selectina L/inmunología , Depleción Linfocítica , Ratones , Ratones Endogámicos NOD , Bazo/citología , Bazo/inmunología , Linfocitos T/citología , Timo/citología , Timo/inmunología

RESUMEN

Splenocytes from nonobese diabetic mice overexpressing murine IL (mIL)-4 upon recombinant retrovirus infection lose their capacity to transfer diabetes to nonobese diabetic-scid recipients. Diabetes appeared in 0-20% of mice injected with mIL-4-transduced cells vs 80-100% of controls injected with beta-galactosidase-transduced cells. Protected mice showed a majority of islets (60%) presenting with noninvasive peri-insulitis at variance with beta-galactosidase controls that exhibited invasive/destructive insulitis. Importantly, in all recipients, the transduced proteins were detected within islet infiltrates. Infiltrating lymphocytes from recipients of mIL-4-transduced cells produced high levels of mIL-4, as assessed by ELISA. In recipients of beta-galactosidase-transduced cells, approximately 60% of TCRalphabeta(+) islet-infiltrating cells expressed beta-galactosidase, as assessed by flow cytometry. The protection from disease transfer is due to a direct effect of mIL-4 gene therapy on immunoregulatory T cells rather than on diabetogenic cells. mIL-4-transduced purified CD62L(-) effector cells or transgenic BDC2.5 diabetogenic T cells still transferred disease efficiently. Conversely, mIL-4 transduction up-regulated the capacity of purified immunoregulatory CD62L(+) cells to inhibit disease transfer. These data open new perspectives for gene therapy in insulin-dependent diabetes using T cells devoid of any intrinsic diabetogenic potential.

Asunto(s)

Adyuvantes Inmunológicos/administración & dosificación , Adyuvantes Inmunológicos/genética , Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 1/prevención & control , Terapia Genética/métodos , Tolerancia Inmunológica/genética , Interleucina-4/genética , Subgrupos de Linfocitos T/inmunología , Traslado Adoptivo , Animales , Movimiento Celular/inmunología , Células Cultivadas , Células Clonales , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 1/patología , Femenino , Vectores Genéticos/administración & dosificación , Vectores Genéticos/inmunología , Inmunidad Activa/genética , Interleucina-4/administración & dosificación , Interleucina-4/biosíntesis , Islotes Pancreáticos/patología , Selectina L/biosíntesis , Transfusión de Linfocitos , Ratones , Ratones Endogámicos NOD , Ratones SCID , Ratones Transgénicos , Receptores de Antígenos de Linfocitos T alfa-beta/genética , Retroviridae/genética , Retroviridae/inmunología , Bazo/citología , Bazo/inmunología , Bazo/trasplante , Bazo/virología , Subgrupos de Linfocitos T/enzimología , Subgrupos de Linfocitos T/trasplante , Subgrupos de Linfocitos T/virología , Transgenes/inmunología , beta-Galactosidasa/administración & dosificación , beta-Galactosidasa/biosíntesis , beta-Galactosidasa/genética

RESUMEN

The period that precedes onset of insulin-dependent diabetes mellitus corresponds to an active dynamic state in which pathogenic autoreactive T cells are kept from destroying beta cells by regulatory T cells. In prediabetic nonobese diabetic (NOD) mice, CD4+ splenocytes were shown to prevent diabetes transfer in immunodeficient NOD recipients. We now demonstrate that regulatory splenocytes belong to the CD4+ CD62Lhigh T cell subset that comprises a vast majority of naive cells producing low levels of IL-2 and IFN-gamma and no IL-4 and IL-10 upon in vitro stimulation. Consistently, the inhibition of diabetes transfer was not mediated by IL-4 and IL-10. Regulatory cells homed to the pancreas and modified the migration of diabetogenic to the islets, which resulted in a decreased insulitis severity. The efficiency of CD62L+ T cells was dose dependent, independent of sex and disease prevalence. Protection mechanisms did not involve the CD62L molecule, an observation that may relate to the fact that CD4+ CD62Lhigh lymph node cells were less potent than their splenic counterparts. Regulatory T cells were detectable after weaning and persist until disease onset, sustaining the notion that diabetes is a late and abrupt event. Thus, the CD62L molecule appears as a unique marker that can discriminate diabetogenic (previously shown to be CD62L-) from regulatory T cells. The phenotypic and functional characteristics of protective CD4+ CD62L+ cells suggest they are different from Th2-, Tr1-, and NK T-type cells, reported to be implicated in the control of diabetes in NOD mice, and may represent a new immunoregulatory population.

Asunto(s)

Linfocitos T CD4-Positivos/inmunología , Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 1/prevención & control , Subgrupos de Linfocitos T/inmunología , Animales , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD4-Positivos/patología , Diferenciación Celular/inmunología , Movimiento Celular/inmunología , Citocinas/biosíntesis , Diabetes Mellitus Tipo 1/etiología , Diabetes Mellitus Tipo 1/patología , Femenino , Inmunofenotipificación , Islotes Pancreáticos/inmunología , Islotes Pancreáticos/patología , Células Asesinas Naturales/inmunología , Selectina L/biosíntesis , Selectina L/fisiología , Masculino , Ratones , Ratones Endogámicos NOD , Ratones SCID , Bazo/inmunología , Bazo/patología , Subgrupos de Linfocitos T/metabolismo , Subgrupos de Linfocitos T/patología , Células Th2/inmunología

RESUMEN

The thymic medulla is a complex microenvironment which plays a crucial role in central tolerance induction. Using a quantitative histological analysis of non-obese diabetic (NOD) mice, we show that the medulla undergoes several structural modifications during the course of the disease in NOD mice. Indeed, the majority of 70-day-old NOD mice show a scattering of medullary epithelial cells in the cortex which is associated with a reduction in the size of the medulla in heavily disorganized thymuses. The severity of this phenotype is shown to correlate with the subsequent appearance of diabetes in older female NOD mice. This trait is mainly controlled by non-major histocompatibility complex NOD genes since C57BL/6 H-2g(7) congenic mice have a normal medulla. It persists in conditions where effector lymphocytes that lead to diabetes are inhibited in periphery. These results suggest that primary alterations of the thymic stroma might play a role in the progression towards diabetes in NOD mice.

Asunto(s)

Enfermedades Autoinmunes/etiología , Diabetes Mellitus Tipo 2/etiología , Timo/patología , Factores de Edad , Animales , Células Epiteliales/patología , Femenino , Antígenos de Histocompatibilidad , Masculino , Ratones , Ratones Endogámicos NOD , Ratones Endogámicos NZB , Fenotipo , Células del Estroma/patología

RESUMEN

Pathogenic autoreactive T lymphocytes are mediators of spontaneous insulin-dependent diabetes in nonobese diabetic (NOD) mice. This is demonstrated by their capacity to transfer diabetes into syngeneic immunoincompetent recipients. In addition, especially in prediabetic NOD mice, peripheral CD4+ T lymphocytes were identified that are highly effective, in conventional mixing cotransfer experiments, at preventing disease transfer. The present data demonstrate that mature heat-stable Ag-TCR alpha beta+CD8-thymocytes from prediabetic NOD mice also express this inhibitory capacity. Selection using an L-selectin (CD62L)-specific Ab showed that TCR alpha/beta+CD4+CD62L+ thymocytes, emerging from the mainstream differentiation pathway, concentrate this ability to regulate autoreactive effectors. Compared with mature TCR alpha beta+CD8- thymocytes, significantly lower numbers of TCR alpha beta+CD4+CD62L+ were sufficient to achieve an efficient inhibition of disease transfer into NOD-scid recipients. This protective ability was potentiated following in vitro culture in the presence of IL-7. In contrast, TCR alpha beta+CD62L- thymocytes, highly enriched in class I-restricted NK T cells, were unable to influence diabetes transfer. Identical results were obtained using thymocytes that have been cultured in vitro for 4 days in the presence of IL-7. These results support the active role in NOD mice of a thymus-derived CD4+ subset that controls peripheral pathogenic autoimmune effectors.

Asunto(s)

Linfocitos T CD4-Positivos/metabolismo , Diabetes Mellitus Tipo 1/inmunología , Tolerancia Inmunológica , Selectina L/biosíntesis , Receptores de Antígenos de Linfocitos T alfa-beta/fisiología , Subgrupos de Linfocitos T/metabolismo , Timo/inmunología , Adyuvantes Inmunológicos/farmacología , Traslado Adoptivo , Animales , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/trasplante , Diferenciación Celular/inmunología , Células Cultivadas , Diabetes Mellitus Tipo 1/etiología , Diabetes Mellitus Tipo 1/prevención & control , Femenino , Inmunidad Activa , Interleucina-7/farmacología , Selectina L/fisiología , Masculino , Ratones , Ratones Endogámicos NOD , Ratones SCID , Bazo/trasplante , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/trasplante , Timo/metabolismo , Timo/trasplante

RESUMEN

Bone marrow (BM) transplantation still must overcome multiple difficulties and should benefit from better understanding of stem-cell homing and mobilization. Here, we analyzed the involvement of several adhesion molecules in the two processes by treating mice with monoclonal antibodies against these molecules. Treatment of lethally irradiated mice grafted with isogeneic BM cells showed that at least two migration pathways are important for stem-cell homing to the BM, whereas only one of them is involved in lodging of colony-forming unit-spleen (CFU-S) in the spleen. We confirm that the VLA-4/VCAM-1 adhesion pathway is important for stem-cell homing to the BM only and show that CD44 is involved in CFU-S lodging in both BM and spleen. These results show that entry of CFU-S into the spleen is regulated. The observation that when one migration pathway is altered, CFU-S do not enter the BM via the other pathway may indicate that the two mechanisms involved in CFU-S homing into the BM are linked. The adhesion molecules VLA-4 and CD44 are also implied in the mobilization of stem cells into the blood stream of mice injected once with anti-VLA-4 or anti-CD44. Anti-VLA-4 administration led to a significant increase in circulating stem cells as early as 8 hours after treatment. Stem cells mobilized by anti-VLA-4 comprise cells with high self-renewal potential and thus may be used for long-term reconstitution of the hematopoietic tissue.

Asunto(s)

Médula Ósea/patología , Movilización de Célula Madre Hematopoyética , Células Madre Hematopoyéticas/citología , Integrinas/fisiología , Receptores Mensajeros de Linfocitos/fisiología , Bazo/patología , Molécula 1 de Adhesión Celular Vascular/fisiología , Animales , Anticuerpos Monoclonales/farmacología , Trasplante de Médula Ósea/patología , Adhesión Celular , Movimiento Celular/fisiología , Ensayo de Unidades Formadoras de Colonias , Femenino , Supervivencia de Injerto , Células Madre Hematopoyéticas/metabolismo , Receptores de Hialuranos/inmunología , Integrina alfa4beta1 , Integrinas/antagonistas & inhibidores , Integrinas/inmunología , Ratones , Ratones Endogámicos BALB C , Especificidad de Órganos , Quimera por Radiación , Receptores Mensajeros de Linfocitos/antagonistas & inhibidores , Receptores Mensajeros de Linfocitos/inmunología , Molécula 1 de Adhesión Celular Vascular/inmunología

RESUMEN

We have previously shown that in the nonobese diabetic (NOD) mouse, an experimental model for autoimmune insulin-dependent diabetes, spleen diabetogenic T cells are contained within the T-cell subpopulation that express no or low levels of L-selectin. This phenotype characterizes activated/memory T cells. In the present study, we have compared the distribution of autoreactive T cells to that of L-selectin -/lo T cells in prediabetic and diabetic mice. Activated/memory T cells were found in decreasing concentrations in the bone marrow (BM), spleen, peritoneum, lymph nodes, and blood. This distribution correlated perfectly with that of T cells capable of transferring diabetes into syngeneic nondiabetic recipients. In diabetic mice, the highest levels of diabetogenic cells were observed in the spleen and BM. The peritoneum and lymph nodes contained intermediate frequencies of autoreactive cells. In the peripheral blood, the number of autoreactive T cells was variable, usually low; in some cases, they were undetectable. These cells were rare in the thymus. Diabetes-transferring cells were present in the spleen and BM of prediabetic mice. In these animals, diabetogenic cells were present in the blood circulation with frequencies higher than in diabetic mice, suggesting that after disease onset, when almost all target beta cells have disappeared, the recirculation of autoreactive cells is greatly decreased and finally stops. These observations: (a) suggest that T cells from BM of prediabetic and diabetic patients may be a better source of diabetogenic cells than the blood for analyzing diabetes-associated responses or for generating diabetogenic T-cell clones, and (b) point up the risk of using healthy autoimmune-prone donors for BM transplantation.

Asunto(s)

Diabetes Mellitus/genética , Diabetes Mellitus/metabolismo , Selectina L/metabolismo , Estado Prediabético/metabolismo , Linfocitos T/patología , Animales , Células de la Médula Ósea/fisiología , Diabetes Mellitus/patología , Memoria Inmunológica/fisiología , Activación de Linfocitos/fisiología , Masculino , Ratones , Ratones Endogámicos NOD , Fenotipo , Linfocitos T/fisiología , Distribución Tisular

Asunto(s)

Matriz Extracelular/ultraestructura , Ingeniería Genética , Timo/citología , Animales , Diferenciación Celular , Ratones , Ratones Noqueados , Ratones Transgénicos , Linfocitos T/citología

RESUMEN

Anti-CD3 MoAb treatment is widely used as an immunosuppressive therapy. In the present study we examined the in vitro T cell response in mice having received 24 h before a single i.v. injection of 10 microgram of anti-CD3 MoAb. We found that splenocytes from these mice displayed a dramatically decreased proliferative response to the T cell mitogens concanavalin A (Con A), anti-CD3, phytohaemagglutinin (PHA) and phorbol myristate acetate (PMA) + calcium ionophore, while the effect of lipopolysaccharide (LPS) was not impaired. T cell suppression persisted for about 10 days after anti-CD3 injection, returning to normal within 15 days. The F(ab')2 fragment of anti-CD3 had no such effect, indicating the requirement for in vivo activation. At the dose used, anti-CD3 resulted neither in T cell depletion nor in down-modulation of the CD3/T cell receptor (TCR) complex. The low proliferation was also not explained by apoptosis, following secondary challenge with Con A. Splenocytes from anti-CD3-injected mice were highly responsive to IL-2, but generated little or no IL-2, IL-3, IL-4 and interferon-gamma (IFN-gamma) when exposed to Con A. Normal cytokine production could not be restored by the addition of optimal doses of IL-2 during Con A stimulation. Transforming growth factor-beta (TGF-beta) was the only cytokine whose mRNA expression was not modified in stimulated splenocytes from anti-CD3-injected mice. Furthermore, anti-TGF-beta antibodies increased Con A-induced T cell proliferation, but not cytokine production.

Asunto(s)

Anticuerpos Monoclonales/farmacología , Complejo CD3/inmunología , Linfocitos T/efectos de los fármacos , Animales , Apoptosis/efectos de los fármacos , Secuencia de Bases , Concanavalina A/farmacología , Cricetinae , Citocinas/biosíntesis , Relación Dosis-Respuesta a Droga , Regulación hacia Abajo/efectos de los fármacos , Femenino , Humanos , Interleucina-2/farmacología , Recuento de Leucocitos , Masculino , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Conejos , Bazo/citología , Linfocitos T/citología , Linfocitos T/inmunología , Factor de Crecimiento Transformador beta/farmacología

RESUMEN

Non-obese diabetic mice spontaneously develop a type 1 diabetes. The entry of leukocytes in the islets of Langerhans was studied in untreated and in irradiated mice. FITC-labeled cells from spleen, lymph nodes or bone marrow of healthy or diabetic donors did home to the inflamed islets of unmanipulated recipients. B and T cells migrated equally well, whereas rare neutrophils entered the islets. Lymphocyte homing was blocked by anti-L-selectin and anti-alpha 4 integrin antibodies. Insulitis transfer experiments using mice congenic at the Thy-1 locus showed that anti-alpha 4 integrin treatment totally inhibited the migration of donor type T cells in the islets, whereas anti-L-selectin only had an early and transient effect. The expression of vascular addressins in the islets was linked to the presence of mononuclear cells. Thus, in the developing islet infiltrate, the entry of cells appears continuous and restricted to lymphocytes, whether autoreactive or not, and involves the L-selectin. This mechanism rather promotes the migration of naive-type cells. Conversely, during the adoptive transfer of insulitis the entry of L-selectin- diabetogenic T cells is highly favored, to the detriment of L-selectin+ naive type cells.

Asunto(s)

Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 1/patología , Islotes Pancreáticos/inmunología , Islotes Pancreáticos/patología , Linfocitos/inmunología , Linfocitos/fisiología , Estado Prediabético/inmunología , Estado Prediabético/patología , Animales , Anticuerpos Monoclonales/farmacología , Antígenos CD/inmunología , Autoinmunidad , Linfocitos B/inmunología , Linfocitos B/patología , Linfocitos B/fisiología , Médula Ósea/inmunología , Médula Ósea/patología , Movimiento Celular/efectos de la radiación , Femenino , Inmunoterapia Adoptiva , Integrina alfa4 , Cinética , Selectina L/inmunología , Linfocitos/patología , Masculino , Ratones , Ratones Endogámicos NOD , Bazo/inmunología , Bazo/patología , Linfocitos T/inmunología , Linfocitos T/patología , Linfocitos T/fisiología

RESUMEN

A simple method was developed for flow cytometric immunofluorescence analysis of cells infiltrating the islets of Langerhans in diabetes-prone rodents. Pancreases were submitted to collagenase P digestion and, in order to minimize collagenase action on leukocytes, islets were isolated before digestion was completed, that is, when exocrine tissue still remained around the islets. Islets, maintained in medium supplemented with sodium azide to prevent modulation of surface markers, were then pressed through a metal sieve and the cell suspension filtered through two different nylon screens. Cells were washed before immunofluorescence staining. Comparative phenotyping of spleen cells submitted to a similar treatment showed that, provided the collagenase P batch was screened, this procedure did not alter leukocyte surface markers and allowed multicolor analysis of the islet infiltrating cells.

Asunto(s)

Separación Celular/métodos , Citometría de Flujo/métodos , Islotes Pancreáticos/patología , Leucocitos Mononucleares/patología , Animales , Colagenasas , Diabetes Mellitus Tipo 1/patología , Femenino , Inmunofenotipificación/métodos , Ratones , Ratones Endogámicos NOD , Bazo/citología

RESUMEN

In the present study, we demonstrate that unresponsive spleen T cells from mice injected with a low dose of anti-CD3 mAb (single 10 micrograms i.v. injection) significantly inhibit Con A-induced proliferation of normal spleen cells. The induction of this phenomenon requires in vivo activation since spleen cells from mice injected with the F(ab')2 fragment of anti-CD3 mAb fail to promote it. Suppression of normal T cell proliferation is concomitant with increased expression of IL-2 receptor on spleen cells from anti-CD3-treated mice. It disappears within 3 days when IL-2R has returned to background levels. A normal proliferative response to Con A can be restored when high concentrations of IL-2 are added together with the "suppressor" cells. Taken together, these data support the notion that activated spleen cells from anti-CD3-injected mice exert their inhibitory effect by competing for the IL-2 generated during culture.

Asunto(s)

Tolerancia Inmunológica , Receptores de Interleucina-2/inmunología , Bazo/inmunología , Animales , Anticuerpos Monoclonales/farmacología , Concanavalina A/farmacología , Cricetinae , Femenino , Activación de Linfocitos , Masculino , Ratones , Ratones Endogámicos C57BL , Receptores de Interleucina-2/antagonistas & inhibidores , Bazo/citología , Linfocitos T/inmunología

RESUMEN

The process of mononuclear cell extravasation from the blood into the islets of Langerhans in nonobese diabetic (NOD) mice is dependent on the expression of a set of molecules, most of which remain to be defined. The observation that vascular addressins are expressed in inflamed islets raises the issue of the involvement of one of their ligands, L-selectin, in the pathogenesis of autoimmune diabetes. Treatment of NOD females with Mel-14, an antibody specific for L-selectin, reduced the spontaneous development of both insulitis and diabetes. Pretreatment of diabetic donors with Mel-14 decreased the capacity of their splenocytes to transfer the disease. However, the treatment of recipients had no effect on the transfer of diabetes by untreated diabetogenic splenocytes. To reconcile these apparently conflicting results, we fractionated spleen T cells from diabetic mice according to L-selectin expression. Diabetogenic cells were found only in the L-selectin subpopulation. Thus, diabetogenic cells in adult mice share phenotypic characteristics with activated/memory cells, and enter the pancreas using L-selectin-independent migratory pathways.

Asunto(s)

Anticuerpos/administración & dosificación , Moléculas de Adhesión Celular/biosíntesis , Diabetes Mellitus Tipo 1/prevención & control , Animales , Moléculas de Adhesión Celular/inmunología , Movimiento Celular/efectos de los fármacos , Trasplante de Células , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 1/patología , Femenino , Selectina L , Leucocitos Mononucleares/metabolismo , Leucocitos Mononucleares/patología , Linfocitos/metabolismo , Linfocitos/patología , Ratones , Ratones Endogámicos NOD , Bazo/metabolismo , Bazo/patología

RESUMEN

The vast majority of spleen T cells (T.sRFC) which spontaneously bind to sheep red blood cells (SRBC) in an antigen-specific fashion express the Thy-1+, CD3+, CD8+ phenotype. Inhibition of rosetting by antibodies to surface molecules occurs via distinct mechanisms according to the antibody. CD8 and CD3 molecules are located in proximity to SRBC receptors and steric hindrance is the most likely explanation for the inhibition of rosetting by antibodies to these molecules. On the other hand, anti-Thy-1 antibody bound to T.sRFC induces a dynamic process involving intracellular cAMP, and which results in the inaccessibility of SRBC receptors. Thymulin could restore normal sensitivity of T.sRFC from adult thymectomized (A.Tx) mice to all inhibitory antibodies whatever the mechanism by which they hinder rosette formation. These results reinforce the idea that thymulin may act on membrane characteristics.

Asunto(s)

Anticuerpos Monoclonales/inmunología , Formación de Roseta/métodos , Subgrupos de Linfocitos T/inmunología , Antígenos Thy-1/inmunología , Animales , Azidas/farmacología , Complejo CD3/inmunología , Antígenos CD8/inmunología , Células Cultivadas , Citocalasina B/farmacología , Eritrocitos/inmunología , Imidazoles/farmacología , Recubrimiento Inmunológico/inmunología , Ratones , Ratones Endogámicos C57BL , Ovinos/inmunología , Azida Sódica , Timectomía , Factor Tímico Circulante/farmacología

RESUMEN

The effect of a single injection of an antibody against the peripheral lymph node (PLN) homing receptor or L-selectin (gp90MEL-14) was studied in vivo in C57BL/6 mice. L-selectin is known to be rapidly shed from leukocytes in humans and in mice following activation or cross-linking in vitro. Here we demonstrate that in vivo a single injection of MEL-14 antibody induces a rapid, almost complete and reversible down-regulation of L-selectin expression on both T and B cells. This modulation is dose dependent, specific for L-selectin and lasts for 10 days. On neutrophils, L-selectin expression was moderately decreased, and the injected antibody was detectable on the cell surface for several days. Thus, L-selectin expression after antibody binding in vivo was affected differently on neutrophils and lymphocytes. MEL-14 treatment induces profound alterations of cell traffic. Loss of L-selectin on lymphocytes leads to drastic PLN depletion and increased spleen cellularity. Depleted PLN were highly enriched in MEL-14-/lo, CD44hi and CD11ahi cells, which may represent transiently sessile memory/activated cells. The unresponsiveness in mixed lymphocyte reaction of PLN cells from treated animals and of purified L-selectin- PLN T cells from normal mice supports this view. However, PLN and spleen cells from treated animals responded normally to non-antigen-specific stimuli.

Asunto(s)

Moléculas de Adhesión Celular/fisiología , Linfocitos/inmunología , Animales , Anticuerpos Monoclonales/inmunología , Reacciones Antígeno-Anticuerpo , Modulación Antigénica , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Inmunofenotipificación , Selectina L , Ganglios Linfáticos/citología , Activación de Linfocitos , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Neutrófilos/inmunología , Bazo/citología , Factores de Tiempo

RESUMEN

The nonobese diabetic mouse is a relevant model for insulin-dependent diabetes mellitus which results from the destruction of pancreatic beta cells by mononuclear cells infiltrating the islets of Langerhans. Other organs such as salivary glands display inflammatory infiltration. Using immunohistochemical and flow cytometry analyses, we have studied the expression of diverse homing and adhesion molecules in salivary glands and the pancreas in nonobese diabetic mice. In salivary glands, ICAM-1 was expressed by endothelial and dendritic cells within the lymphocytic infiltration. HEV-like structures expressing PNAd were observed in the areas of lymphocytic infiltration whereas MAdCAM-1 was absent. Lymphocytes infiltrating salivary glands expressed LFA-1 and Pgp-1 although Mel-14 Ag was absent. In infiltrated islets, ICAM-1 was expressed by endothelial cells, dendritic cells, and mononuclear cells. We confirm the presence of HEV-like structures expressing MAdCAM-1 and PNAd in inflamed islets. With regard to peripheral lymphocytes, the proportion of CD4 and CD8 cells expressing Mel-14 was decreased in the infiltrated islets, whereas the expression of LFA-1, Pgp-1, and LPAM-1/2 was increased. B lymphocytes exhibited up-regulation of LPAM-1/2. Moreover, the proportion of CD4, CD8, and B lymphocytes expressing CD69 was increased in the pancreas. These results indicate that first, infiltration of islets of Langerhans results at least partly from modifications of adhesion molecule expression in the pancreas, which allow extravasation of mononuclear cells into the islets via at least three different pathways; and second, that activated cells are concentrated in the infiltrates as compared with peripheral lymphoid organs.

Asunto(s)

Moléculas de Adhesión Celular/metabolismo , Diabetes Mellitus Tipo 1/inmunología , Receptores Mensajeros de Linfocitos/metabolismo , Animales , Movimiento Celular/inmunología , Diabetes Mellitus Tipo 1/patología , Inmunohistoquímica , Islotes Pancreáticos/inmunología , Islotes Pancreáticos/patología , Subgrupos Linfocitarios/inmunología , Subgrupos Linfocitarios/patología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Endogámicos NOD , Glándulas Salivales/inmunología , Glándulas Salivales/patología

Asunto(s)

Enfermedades Autoinmunes/metabolismo , Moléculas de Adhesión Celular/metabolismo , Diabetes Mellitus Tipo 1/metabolismo , Endotelio Vascular/metabolismo , Islotes Pancreáticos/patología , Subgrupos Linfocitarios/metabolismo , Receptores Mensajeros de Linfocitos/metabolismo , Animales , Enfermedades Autoinmunes/patología , Movimiento Celular , Diabetes Mellitus Tipo 1/patología , Endotelio Vascular/patología , Femenino , Citometría de Flujo , Inmunofenotipificación , Islotes Pancreáticos/irrigación sanguínea , Islotes Pancreáticos/inmunología , Subgrupos Linfocitarios/patología , Masculino , Ratones , Ratones Endogámicos NOD , Vénulas

RESUMEN

Subpopulations of lymphoid cells were compared with respect to their ability to migrate into peripheral lymphoid organs of nonobese diabetic (NOD) mice and various strains of control mice. In short-term, in vivo homing studies, no major differences in the pattern of homing of B and T cells were observed among all mouse strains studied. On the other hand, CD4 cells localized consistently more efficiently than CD8 cells in both PP and LN of adult NOD and BALB/c mice, whereas both populations migrated roughly equivalently in LN of adult DBA/2, CBA, and C57BL/6 mice. No age-dependent differences in the homing of CD4 and CD8 cells were observed in BALB/c mice. On the contrary, in 2-week-old NOD mice, CD4 and CD8 cells migrated equally well. The preferential entry of CD4 cells in adult NOD and BALB/c did not result from increased blood transit time of CD8 cells. On the other hand, the preferential migration of CD8 cells was observed in the liver, whereas the two T-cell subsets migrated equally well in the lungs. The differences in the homing characteristics of CD4 and CD8 cells among NOD, BALB/c, and C57BL/6 mice were not related to modifications in the level of expression of adhesion molecules such as MEL-14, LFA-1, and Pgp-1.

Asunto(s)

Linfocitos T CD4-Positivos/citología , Linfocitos T CD8-positivos/citología , Ganglios Linfáticos/citología , Factores de Edad , Animales , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD8-positivos/metabolismo , Moléculas de Adhesión Celular/biosíntesis , Movimiento Celular/genética , Células Cultivadas , Femenino , Hígado/citología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Endogámicos NOD/genética